Pharmanutra S.p.A.

DB:761 Stock Report

Market Cap: €768.9m

Pharmanutra Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 761?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,068,79511.2%
General Public2,204,72523%
Individual Insiders6,301,66365.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.7%
Andrea Lacorte
3,038,334€244.0m0%no data
23.4%
Roberto Lacorte
2,242,833€180.1m0%no data
10.7%
Carlo Volpi
1,020,496€81.9m0%no data
3.49%
Norges Bank Investment Management
334,575€26.9m0%no data
0.93%
Joh. Berenberg, Gossler & Co. KG
88,819€7.1m0%0.37%
0.72%
Danske Bank A/S
68,832€5.5m0%0.04%
0.63%
Mirabaud Asset Management Ltd.
60,148€4.8m0%0.48%
0.55%
Lupus Alpha Asset Management GmbH
53,000€4.3m0%0.36%
0.54%
Kairos Partners SGR SpA
51,813€4.2m0%0.59%
0.53%
Polar Capital Holdings Plc
50,909€4.1m64.7%0.01%
0.48%
Dimensional Fund Advisors LP
46,332€3.7m9.21%no data
0.47%
BlackRock, Inc.
44,937€3.6m4.76%no data
0.46%
Lupus alpha Investment GmbH
44,000€3.5m0%0.98%
0.43%
Amundi Asset Management SAS
41,257€3.3m0%no data
0.38%
Pharus Management SA
36,500€2.9m0%0.4%
0.37%
Allianz Asset Management GmbH
35,222€2.8m0%no data
0.31%
Mandarine Gestion
30,150€2.4m0%0.23%
0.18%
Intermonte SIM S.p.A.
17,568€1.4m0%2.47%
0.16%
Invesco Great Wall Fund Management Co. Ltd
14,900€1.2m0%no data
0.13%
Fondita Rahastoyhtio AB
12,831€1.0m0%0.24%
0.12%
Grandeur Peak Global Advisors, LLC
11,849€951.5k-23%0.04%
0.12%
Ersel Asset Management Sgr S.p.A.
11,245€903.0k0%0.14%
0.095%
ODDO BHF Asset Management SAS
9,133€733.4k0%0.01%
0.075%
Azimut Capital Management Sgr SpA
7,151€574.2k0%0.01%
0.072%
Deutsche Asset & Wealth Management
6,856€550.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/15 00:02
End of Day Share Price 2026/04/15 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharmanutra S.p.A. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anna FrontaniBerenberg
Andrea RandoneIntermonte SIM S.p.A.
Giorgio TavoliniIntermonte SIM S.p.A.